OPKO HEALTH, INC.
Last · Tel AvivILA 407.50-16.10 (-3.80%)close · yahoo · 15h ago
Market capILA 3.0B746.3M sh
P/E · TTM-1405fwd — · eps -0.29 · loss
Beta1.50vs S&P 500
Div yield0.00%annual · TTM
52w range
ILA 310.00ILA 526.50
Volume219.7Ksession
| Revenue | $287.8M |
|---|---|
| Operating income | $-58.0M |
| Net income | $-63.3M |
| Free cash flow | $-67.6M |
| Operating margin | -20.1% |
| Net margin | -22.0% |
| Return on equity | -5.3% |
| Period | 2026 |
Loading chart…
Upcoming earnings
3:30 PM UTC+1
Period
Sep 2026
Est. EPS
—
Est. revenue
136.6M
Earnings transcripts
Press & signals
- GlobeNewswire
OPKO Health Expands Strategic Relationship with HealthCare Royalty Through $125 Million Notes Issuance Secured by Mazdutide Royalty Interests
- GlobeNewswire
OPKO Health Reports Second Quarter 2026 Business Highlights and Financial Results
Documents
FormReporting forFiledFlags